TITLE:
      Alternate-Day Buprenorphine Administration. Phase VIII - 9
SUMMARY:
      The purpose of this study is to evaluate open buprenorphine dosing with dose choice.
ELIGIBILITY CRITERIA:
      Please contact site for information.
